Behrang Kazeminezhad et al. 2019. Usefulness of insulin-like growth factor II mRNA-binding protein 3 (IMP3) as a new marker for the diagnosis of esophageal adenocarcinoma in challenging cases. Turkish Journal of Gastroenterology. 25, 3 (Jul. 2019), 253–256.